Cells with immunoregulatory properties and their impact in the pathogenesis of sepsis;Células con propiedades inmunoreguladoras y su impacto en la patogénesis de la sepsis

Revista Chilena de Infectologia

Volumn 28, Issue 6, 2011, Pages 572-578

  Diosa Toro, Mayra A ^a   Jaimes B, Fabián A ^b   Rugeles L, María T ^a   Velilla H, Paula A ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b Hospital Universitario San Vicente de Paul   (Colombia)

Author keywords

Dendritic cells; Gamma delta t lymphocytes; Immunology; Invariant natural killer t cells; Natural killer cells; Pathology; Sepsis

Indexed keywords

CELLULAR IMMUNITY; CYTOLOGY; DENDRITIC CELL; DOWN REGULATION; HUMAN; IMMUNOLOGY; NATURAL KILLER CELL; REVIEW; SEPSIS; T LYMPHOCYTE;

DENDRITIC CELLS; DOWN-REGULATION; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; SEPSIS; T-LYMPHOCYTES;

EID: 84855462368     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-10182011000700010     Document Type: Review

References (65)

1. Angus D C, Linde-Zwirble W T, Lidicker J, Clermont G, Carcillo J, Pinsky M R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29 (7): 1303-10.
2. Jaimes F. A literature review of the epidemiology of sepsis in Latin America. Rev Panam Salud Pública 2005; 18 (3): 163-71.
3. Levy M M, Fink M P, Marshall J C, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31 (4): 1250-6.
4. Bone R C, Balk R A, Cerra F B, Dellinger R P, Fein A M, Knaus W A, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/ SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-55.
5. Hotchkiss R S, Karl I E. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348 (2): 138-50.
6. Van der Poll T, Opal S M. Host-pathogen interactions in sepsis. Lancet Infect Dis 2008; 8 (1): 32-43.
7. Gao H, Leaver S K, Burke-Gaffney A, Finney S J. Severe sepsis and toll-like receptors. Semin Immunopathol 2008; 30 (1): 29-40.
8. Sriskandan S, Altmann D M. The immunology of sepsis. J Pathol 2008; 214 (2): 211-23.
9. Flaster H, Bernhagen J, Calandra T, Bucala R. The macrophage migration inhibitory factorglucocorticoid dyad: regulation of inflammation and immunity. Mol Endocrinol 2007; 21 (6): 1267-80.
10. Calandra T, Echtenacher B, Roy D L, Pugin J, Metz C N, Hultner L, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6 (2): 164-70.
11. Bozza M, Satoskar A R, Lin G, Lu B, Humbles A A, Gerard C, et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999; 189 (2): 341-6.
12. Andersson U, Wang H, Palmblad K, Aveberger A C, Bloom O, Erlandsson-Harris H, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192 (4): 565-70.
13. Bone R C, Grodzin C J, Balk R A. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997; 112 (1): 235-43.
14. Zeni F, Freeman B, Natanson C. Antiinflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997; 25 (7): 1095-100.
15. Wang T S, Deng J C. Molecular and cellular aspects of sepsis-induced immunosuppression. J Mol Med 2008; 86 (5): 495-506.
16. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk A H. Identification and functional characterization of human CD4(+) CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193 (11): 1285-94.
17. Liu W, Putnam AL, Xu-Yu Z, Szot G L, Lee M R, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203 (7): 1701-11.
18. Campbell D J, Ziegler S F. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol 2007; 7 (4): 305-10.
19. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005; 6 (4): 338-44.
20. Belkaid Y, Rouse B T. Natural regulatory T cells in infectious disease. Nat Immunol 2005; 6 (4): 353-60.
21. Monneret G, Debard A L, Venet F, Bohe J, Hequet O, Bienvenu J, et al. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2003; 31 (7): 2068-71.
22. Venet F, Pachot A, Debard A L, Bohe J, Bienvenu J, Lepape A, et al. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes. Crit Care Med 2004; 32: 2329-31.
23. Saito K, Wagatsuma T, Toyama H, Ejima Y, Hoshi K, Shibusawa M, et al. Sepsis is characterized by the increases in porcentages of circulating CD4+CD25+ regulatory T cells and plasma levels of soluble CD25. J Exp Med 2008; 216: 61-8.
24. MacConmara M P, Maung A A, Fujimi S, McKenna A M, Delisle A, Lapchak P H, et al. Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg 2006; 244 (4): 514-23.
25. Wisnoski N, Chung C S, Chen Y, Huang X, Ayala A. The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis. Shock 2007; 27 (3): 251-7.
26. Scumpia P O, Delano M J, Kelly K M, O'Malley K A, Efron P A, McAuliffe P F, et al. Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis J Immunol 2006; 177: 7943-9.
27. Venet F, Chung C S, Kherouf H, Geeraert A, Malcus C, Poitevin F, et al. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Medicine 2009; 35 (4): 678-86.
28. Monneret G, Venet F, Pachot A, Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 2008; 14 (1-2): 64-78.
29. Heath W R, Belz G T, Behrens G M, Smith C M, Forehan S P, Parish I A, et al. Cross presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 2004; 199: 9-26.
30. Sirgo G, Claramonte R, Chanovas M, Esteban F, Forcadell I, Luna J, et al. Dendritic cells in sepsis: an approach to post-infectious immunosuppression. Med Intensiva; 34 (8): 559-66.
31. Efron P A, Martins A, Minnich D, Tinsley K, Ungaro R, Bahjat F R, et al. Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis. J Immunol 2004; 173 (5): 3035-43.
32. Scumpia P O, McAuliffe P F, O'Malley K A, Ungaro R, Uchida T, Matsumoto T, et al. CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis. J Immunol 2005; 175 (5): 3282-6.
33. Flohe S B, Agrawal H, Schmitz D, Gertz M, Flohe S, Schade F U. Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response. J Leukoc Biol 2006; 79 (3): 473-81.
34. Wen H, Dou Y, Hogaboam C M, Kunkel S L. Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response. Blood 2008; 111 (4): 1797-804.
35. Hotchkiss R S, Tinsley K W, Swanson P E, Grayson M H, Osborne D F, Wagner T H, et al. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 2002; 168 (5): 2493-500.
36. Guisset O, Dilhuydy M S, Thiebaut R, Lefevre J, Camou F, Sarrat A, et al. Decrease in circulating dendritic cells predicts fatal outcome in septic shock. Intensive Care Med 2007; 33 (1): 148-52.
37. Cooper M A, Fehniger T A, Caligiuri M A. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22 (11): 633-40.
38. Enoh V T, Lin S H, Lin C Y, Toliver-Kinsky T, Murphey E D, Varma T K, et al. Mice depleted of alphabeta but not gammadelta T cells are resistant to mortality caused by cecal ligation and puncture. Shock 2007; 27 (5): 507-19.
39. Sherwood E R, Enoh V T, Murphey E D, Lin C Y. Mice depleted of CD8+ T and NK cells are resistant to injury caused by cecal ligation and puncture. Lab Invest 2004; 84 (12): 1655-65.
40. Goldmann O, Chhatwal G S, Medina E. Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice. J Infect Dis 2005; 191 (8): 1280-6.
41. Diefenbach A, Jamieson A M, Liu S D, Shastri N, Raulet D H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000;1 (2): 119-26.
42. Wilson M T, Johansson C, Olivares-Villagomez D, Singh A K, Stanic A K, Wang C R, et al. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci U S A 2003; 100 (19): 10913-8.
43. Sidobre S, Naidenko O V, Sim B C, Gascoigne N R, García K C, Kronenberg M. The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J Immunol 2002; 169 (3): 1340-8.
44. Smyth M J, Thia K Y, Street S E, Cretney E, Trapani JA, Taniguchi M, et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 2000; 191 (4): 661-8.
45. van der Vliet H J, von Blomberg B M, Nishi N, Reijm M, Voskuyl A E, van Bodegraven A A, et al. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol 2001; 100 (21): 44-8.
46. Godfrey D I, Hammond K J, Poulton L D, Smyth M J, Baxter A G. NKT cells: facts, functions and fallacies. Immunol Today 2000; 21 (11): 573-83.
47. Gumperz J E, Miyake S, Yamamura T, Brenner M B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 2002; 195 (5): 625-36.
48. Nicol A, Nieda M, Koezuka Y, Porcelli S, Suzuki K, Tadokoro K, et al. Dendritic cells are targets for human invariant Valpha24+ natural killer T-cell cytotoxic activity: an important immune regulatory function. Exp Hematol 2000; 28 (3): 276-82.
49. Dieli F, Sireci G, Russo D, Taniguchi M, Ivanyi J, Fernández C, et al. Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J Exp Med 2000; 192 (11): 1645-52.
50. Tsujimoto H, Ono S, Matsumoto A, Kawabata T, Kinoshita M, Majima T, et al. A critical role of CpG motifs in a murine peritonitis model by their binding to highly expressed toll-like receptor-9 on liver NKT cells. J Hepatol 2006; 45 (6): 836-43.
51. Stevenson H L, Crossley E C, Thirumalapura N, Walker D H, Ismail N. Regulatory roles of CD1d-restricted NKT cells in the induction of toxic shock-like syndrome in an animal model of fatal ehrlichiosis. Infect Immun 2008; 76 (4): 1434-44.
52. Rhee R J, Carlton S, Lomas J L, Lane C, Brossay L, Cioffi W G, et al. Inhibition of CD1d activation suppresses septic mortality: a role for NK-T cells in septic immune dysfunction. J Surg Res 2003; 115 (1): 74-81.
53. Faunce D E, Gamelli R L, Choudhry M A, Kovacs E J. A role for CD1d-restricted NKT cells in injury-associated T cell suppression. J Leukoc Biol 2003; 73 (6): 747-55.
54. Cipriani B, Borsellino G, Poccia F, Placido R, Tramonti D, Bach S, et al. Activation of C-C beta-chemokines in human peripheral blood gammadelta T cells by isopentenyl pyrophosphate and regulation by cytokines. Blood 2000; 95 (1): 39-47.
55. Ferrick D A, Schrenzel M D, Mulvania T, Hsieh B, Ferlin W G, Lepper H. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2- stimulating pathogens by gamma delta T cells in vivo. Nature 1995; 373 (6511): 255-7.
56. Girardi M, Lewis J, Glusac E, Filler R B, Geng L, Hayday A C, et al. Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation. J Exp Med 2002; 195 (7): 855-67.
57. Mukasa A, Yoshida H, Kobayashi N, Matsuzaki G, Nomoto K. Gamma delta T cells in infection-induced and autoimmune-induced testicular inflammation. Immunology 1998; 95 (3): 395-401.
58. Van Damme N, De Keyser F, Demetter P, Baeten D, Mielants H, Verbruggen G, et al. The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome. Clin Exp Immunol 2001; 125 (3): 383-90.
59. Girardi M, Sherling M A, Filler R B, Shires J, Theodoridis E, Hayday AC, et al. Antiinflammatory effects in the skin of thymosinbeta4 splice-variants. Immunology 2003; 109 (1): 1-7.
60. Moore T A, Moore B B, Newstead M W, Standiford T J. Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia. J Immunol 2000; 165 (5): 2643-50.
61. Chung C S, Watkins L, Funches A, Lomas- Neira J, Cioffi W G, Ayala A. Deficiency of gammadelta T lymphocytes contributes to mortality and immunosuppression in sepsis. Am J Physiol Regul Integr Comp Physiol 2006; 291 (5): R1338-43.
62. O'Brien R L, Yin X, Huber S A, Ikuta K, Born W K. Depletion of a gamma delta T cell subset can increase host resistance to a bacterial infection. J Immunol 2000; 165 (11): 6472-9.
63. Venet F, Bohe J, Debard AL, Bienvenu J, Lepape A, Monneret G. Both percentage of gammadelta T lymphocytes and CD3 expression are reduced during septic shock. Crit Care Med 2005; 33 (12): 2836-40.
64. Matsushima A, Ogura H, Fujita K, Koh T, Tanaka H, Sumi Y, et al. Early activation of gammadelta T lymphocytes in patients with severe systemic inflammatory response syndrome. Shock 2004; 22 (1):11-5.
65. Vincent J L, Sun Q, Dubois M J. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis 2002; 34 (8): 1084-93.